Remove Competition Remove Medicine Remove Prescription
article thumbnail

Pharmacy benefit managers inflate drug prices and decrease competition while consumers pay the price. Does the FTC have the medicine to fix it?

MedCity News

Many have never heard of a pharmacy benefit manager, mega-profitable companies that control what consumers pay for prescription drugs. The FTC’s new probe needs to go far to change the status quo.

article thumbnail

 The US accounts for more than 40% of all health spending.

World of DTC Marketing

The lack of choice limits competition, which can drive prices higher. According to KFF, “ the cost of health care often prevents people from getting needed care or filling prescriptions. Three in ten (29%) also report not taking their medicines as prescribed at some point in the past year because of the cost. Half of U.S.

Insurance 154
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novartis said to be eyeing sale of ophthalmology, respiratory units

pharmaphorum

Novartis has already spun out its eyecare business Alcon, and is now considering the sale of its ophthalmology and respiratory medicines businesses as it continues a narrowing of its focus, according to media reports. Meanwhile, Lucentis sales have been in decline as a result of biosimilar competition, contracting 11% to $1.55

Sales 124
article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

1 For use as prescription drugs, a botanical product must be approved by the FDA: to date, only two have gained this approval. 2 Approach taken by regulators in the UK The Medicines and Healthcare products Regulatory Agency regulates herbal medicines in the UK. 2012/1916). 2012/1916). 2012/1916).

Marketing 103
article thumbnail

Inflation threatens supply of life-saving generics to Europe

Pharmaceutical Technology

On November 16, 2022, Medicines for Europe (MFE), the generics and biosimilars body, called for EU and national reforms to improve the security of medicine supplies, including tackling the impact of inflation on the security of essential medicine supplies with smart procurement guidelines for medicine.

article thumbnail

Shareholders versus patients: Who is more important?

World of DTC Marketing

SKIMMERS SUMMARY: There is one and only one social responsibility of business–to use its resources and engage in activities designed to increase its profits so long as it stays within the rules of the game, which is to say, engages in open and free competition without deception or fraud. We try never to forget that medicine is for the people.

Patients 156
article thumbnail

The Importance of Omnichannel Approach for European Physicians

PM360

But alarmingly for reps, and the European marketing teams that rely heavily on their sales force to raise awareness of their medicines, a further 25% of physicians told us that they wanted to decrease how often they interacted with reps in the future.